Att C _ RFP 72117 - Pricing Table.xlsx
XLSX spreadsheet 18 KB Posted
- Solicitation number
- 75D301-22-R-72117
About this file
This document contains a solicitation for a repeat serologic survey to estimate SARS-CoV-2 seroprevalence across the United States. The Centers for Disease Control and Prevention requires contracts for Offerors to collect excess blood specimens from commercial laboratories nationwide, test the specimens for SARS-CoV-2 antibodies using specified assays, and report aggregate findings to CDC after each eight-week collection period. Offerors may propose on any or all required tests, which include qualitative anti-nucleocapsid and quantitative anti-spike antibody assays, as well as reflexive microneutralization testing. The base period of performance is eleven months from February 21, 2022 through January 20, 2023, with an option period of an additional twelve months. Questions are due by January 6, 2022 and proposals are due by January 24, 2022 to the CDC Office of Acquisition Services. Pricing terms and the number of specimens to be tested are to be provided by Offerors in the specified attachments.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Att B (amended) _ Task Deliverables Table.xlsx | XLSX spreadsheet | |
| Att C (amended) _ Pricing Table.xlsx | XLSX spreadsheet | |
| Responses to Vendor QA - Att D_Question and Answer Template.xlsx | XLSX spreadsheet | |
| Solicitation Amendment _ Sec. D PWS - RFP 75D301-22-R-72117.docx | DOCX document | |
| RFP 75301-22-R-72117 - MASS-C Serology.doc | DOC document | |
| Att D _ RFP 72117 - Question and Answer Template.xlsx | XLSX spreadsheet | |
| Att A _ RFP 72117 - Offeror Capabilities and Specimens.xlsx | XLSX spreadsheet | |
| Att B _ RFP 72117 - Task Deliverables Table.xlsx | XLSX spreadsheet |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Attachment C
| RFP 75D301-22-R-72117: MULTISTATE ASSESSMENT OF SARS-CoV-2 SEROPREVALENCE | |||||||||||||||
| Base Period: 2/21/2022 - 1/20/2023 | |||||||||||||||
| Offeror Name | Offered Sites | Number of sites | Shipping Unit Price | Shipping Quantity/Unit | Estimated samples per 4 week collection period | Task Area 1 Unit Price Assay A (anti-S quantitative assay) | Task Area 1 Unit Price Assay B (anti-N qualitative assay) | Task Area 1 Assay A Bimonthly Total | Task Area 1 Assay B Bimonthly Total | Task Area 1 Bimonthly Totals | Estimated total contract samples | Task Area 1 Totals | Task Area 2 Unit Price (1 curve) | Task Area 2 Unit Price (2 curve) | Task Area 2 Unit Price (3 curve) |
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Option Period: 12/05/2022 - 12/04/2023 | |||||||||||||||
| Offeror Name | Offered Sites | Number of sites | Shipping Unit Price | Shipping Quantity/Unit | Estimated samples per 4 week collection period | Task Area 1 Unit Price Assay A (anti-S quantitative assay) | Task Area 1 Unit Price Assay B (anti-N qualitative assay) | Task Area 1 Assay A Bimonthly Total | Task Area 1 Assay B Bimonthly Total | Task Area 1 Bimonthly Totals | Estimated total contract samples | Task Area 1 Totals | Task Area 2 Unit Price (1 curve) | Task Area 2 Unit Price (2 curve) | Task Area 2 Unit Price (3 curve) |
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| ADDITIONAL PEDIATRIC SPECIMENS | ||
| Period of | ||
| Performance | Number of Units Proposed | Price |
| Base Period |
(2/21/22 - 1/20/23) Option Period (12/5/22 - 12/4/23)
File details come from the government source that posted it. Updated .